A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study
Open Access
- 30 March 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 10 (1), 119
- https://doi.org/10.1186/1471-2407-10-119
Abstract
There is renewed interest in magnetic hyperthermia as a treatment modality for cancer, especially when it is combined with other more traditional therapeutic approaches, such as the co-delivery of anticancer drugs or photodynamic therapy. The influence of bimagnetic nanoparticles (MNPs) combined with short external alternating magnetic field (AMF) exposure on the growth of subcutaneous mouse melanomas (B16-F10) was evaluated. Bimagnetic Fe/Fe3O4 core/shell nanoparticles were designed for cancer targeting after intratumoral or intravenous administration. Their inorganic center was protected against rapid biocorrosion by organic dopamine-oligoethylene glycol ligands. TCPP (4-tetracarboxyphenyl porphyrin) units were attached to the dopamine-oligoethylene glycol ligands. The magnetic hyperthermia results obtained after intratumoral injection indicated that micromolar concentrations of iron given within the modified core-shell Fe/Fe3O4 nanoparticles caused a significant anti-tumor effect on murine B16-F10 melanoma with three short 10-minute AMF exposures. We also observed a decrease in tumor size after intravenous administration of the MNPs followed by three consecutive days of AMF exposure 24 hrs after the MNPs injection. These results indicate that intratumoral administration of surface modified MNPs can attenuate mouse melanoma after AMF exposure. Moreover, we have found that after intravenous administration of micromolar concentrations, these MNPs are capable of causing an anti-tumor effect in a mouse melanoma model after only a short AMF exposure time. This is a clear improvement to state of the art.Keywords
This publication has 23 references indexed in Scilit:
- N-Propionyl-Cysteaminylphenol-Magnetite Conjugate (NPrCAP/M) Is a Nanoparticle for the Targeted Growth Suppression of Melanoma CellsJournal of Investigative Dermatology, 2009
- Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle deliveryJournal of Biophotonics, 2009
- Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional NanoparticlesGastroenterology, 2009
- Evaluation of the tolerance and distribution of intravenously applied ferrofluid particles of 250 and 500 nm size in an animal modelJournal of Drug Targeting, 2009
- Is Anticancer Drug Development Heading in the Right Direction?Cancer Research, 2009
- On the Correlation Between Hydrophobicity, Liposome Binding and Cellular Uptake of Porphyrin SensitizersPhotochemistry and Photobiology, 2006
- Toxicity and Tissue Distribution of Magnetic Nanoparticles in MiceToxicological Sciences, 2005
- Magnetic nanoparticle design for medical diagnosis and therapyJournal of Materials Chemistry, 2004
- Functional magnetic particles for medical applicationJournal of Bioscience and Bioengineering, 2002
- Effects of Magnetic Fluid Hyperthermia (MFH) on C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1997